Cookie Einstellungen

Zur Optimierung der Benutzerfreundlichkeit setzen wir Cookies ein. Wählen Sie aus, welche Cookies diese Webseite verwenden darf.  Datenschutzerklärung

Nur technisch erforderliche Cookies, die für die grundlegenden Funktionen unserer Webseite nötig sind, werden gesetzt.

Search

Analytics

  • Ref-No.Technology
  • 01-00976NMR glass capillary sealing device
  • 03-00359mRNA interactome capture
  • 03-00459Autofocus-control of a microscope including an electrically tunable lens
  • 03-00462SPACE-Seq: Localizing Spatial Gene Expression on Single-Cell Level
  • 06-00053Cost-efficient Disposable Filtration Microtiter Plates for High Throughput Applications
  • 14-00022Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
  • 14-00073Improved endotoxin test for the quality control of biologics, overcoming low endotoxin recovery (LER) / low lipopolysaccharide recovery (LLR) phenomenon
  • 15-00385LNCRNAS GADLOR 1 + 2 FOR DIAGNOSIS AND TREATMENT OF CARDIAC HYPERTROPHY
  • 22-00022Gene List Significance Index
  • 32-00030Method and arrangement for identification and correction of optical aberrations
  • 32-00071A sensitive assay for measuring extracellular NAD+ in blood and other human body fluids
  • 44-00001Technology enabling a comprehensive analysis of blood flow in vessels
   Clear all

Animal Models

  • Ref-No.Technology
  • 002249B10.129S2(B6)-Igh-6tm1Cgn/J
  • 002250B10.129P2(B6)-Il10tm1Cgn/J
  • 002251B6.129P2-Il10tm1Cgn/J
  • 002253B6.129P2-Il4tm1Cgn/J
  • 002288B6.129S2-Igh-6tm1Cgn/J
  • 002397129-Cd5tm1Cgn/J
  • 002399129-Igh-5tm1Cgn/J
  • 002400C57BL/6-Igk-Ctm1Cgn/J
  • 002401B6.129S2-Igll1tm1Cgn/J
  • 002405B6.129P2-Ncam1tm1Cgn/J
  • 002438B6.129P2-Igh-Jtm1Cgn/J
  • 002479STOCK Il2rgtm1Cgn/J
  • 002527STOCK Tg(Mx1-cre)1Cgn/J
  • 002538C.129P2(B6)-Igh-5tm1Cgn/J
  • 002858STOCK Tg(balancer1)2Cgn/J
  • 002859STOCK Tg(balancer2)3Cgn/J
  • 002965C57BL/6-Itgb7tm1Cgn/J
  • 003465BALB/c-Tg(CMV-cre)1Cgn/J
  • 003556B6.Cg-Tg(Mx1-cre)1Cgn/J
  • 003968C3Bir.129P2(B6)-Il10tm1Cgn/J
  • 004126C.129P2-Cd19tm1(cre)Cgn/J
  • 004192STOCK Mttptm2Sgy Ldlrtm1Her Apobtm2Sgy Tg(Mx1-cre)1Cgn/J
  • 004222NOD.129P2(B6)-Il4tm1Cgn/DvsJ
  • 004254NOD.Cg-Igh-6tm1Cgn Tg(IghelMD4)4Ccg/Dvs
  • 004266NOD.Cg-Il10tm1Cgn/DvsJ
  • 004291NOD.Cg-Il10tm1Cgn Il4tm1Cgn/DvsJ
  • 004326C3Bir.129P2(B6)-Il10tm1Cgn/Lt
  • 004333C.129P2(B6)-Il10tm1Cgn/J
  • 004349C.129S2-Igh-6tm1Cgn/J
  • 004368129-Il10tm1Cgn/J
  • 004639NOD.129S2(B6)-Igh-6tm1Cgn/DoiJ
  • 004781B6.129P2-Lyzstm1(cre)Ifo/J
  • 004943NOD.Cg-Selltm1Tft Itgb7tm1Cgn/LtJ
  • 004944NOD.B6-Itgb7tm1Cgn/2Lt
  • 004982C3Bir.Cg-Il10tm1Cgn (D3Mit11-D3Mit19)/Lt
  • 005306NODCaj.Cg-Igh-6tm1Cgn Tg(Igh-VB1-8/Igh-6m)1Mjsk/FswJ
  • 005309NODCaj.Cg-Igh-6tm1Cgn Tg(Igh-VB1-8/Igh-6)2Mjsk/FswJ
  • 02-00330Mouse models for liver immunity and therapeutic vaccinations
  • 03-00144Mice with Kidney-specific Megalin Gene Defect
  • 03-00145Kinin B1 Receptor Knock-Out Mice
  • 03-00184Double-Transgenic Rats as a Tool to Study the Function of the Renin-Angiotensin System
  • 03-00188Tryptophan Hydroxylase 1 Knockout Mice as a Tool to Study the Function of Serotonin
  • 03-00189TGR(hKLK1) Transgenic rats as a Tool to Study the Kallikrein-Kinin System
  • 03-00190Angiotensinogen Transgenic Mice TGM(rAOGEN)123
  • 03-00202Renin Transgenic Rat TGR(mREN2)27
  • 03-00238Conductin+/lacZ-mice as a model for Wnt-mediated tumorigenesis
  • 03-00244CCR7 -/- mice: a model for studies on early immune reponses towards alloantigens
  • 03-00249SLP3 mutant mice; an animal model lacking touch-evoked neuropathic pain
  • 03-00300Animal model for endotoxic shock: transgenic rats with endothelial overexpression of kinin B1 receptors
  • 03-00495A titin-DsRed knock-in mouse model to study cardiac and skeletal muscle disorders
  • 03-00504A titin-eGFP knock-in mouse model to study cardiac and skeletal muscle disorders
  • 11-00041PARP1 -/- mice: an animal model for cancer, autoimmune encephalomyelitis, arthritis and diabetes
  • 11-00046GFP Transgenic Zebrafish strain as tool for studying kidney development
  • 21-00013aMAG -/- mice: a model for studying pathological mechanisms of acquired demyelinating diseases
  • 21-00013bTenascin-R knock-out mice
  • 21-00013cCHL1 -/- mice: a model for studying the function of the close homologue of adhesion molecule L1
   Clear all

Antibodies

  • Ref-No.Technology
  • 03-00397Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
  • 10-00064Highly-sensitive, highly-specific recombinant BMP-2 and BMP-14 antibodies
  • 14-00013MAdL monoclonal antibody: A novel, highly specific and sensitive biomarker for adenocarcinomas of the lung
  • 14-00022Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
  • 14-00073Improved endotoxin test for the quality control of biologics, overcoming low endotoxin recovery (LER) / low lipopolysaccharide recovery (LLR) phenomenon
  • 23-00080Neutralizing Antibodies for Treatment of COVID19 Infection
  • 17beta-HSDcl
  • ACP33 acidic cluster protein 33, ligand of CD4
  • ActA purified, several epitopes
  • Activation-induced cytidine deaminase (AID)
  • Adenovirus type 5, E1B-55 kDa
  • Adenovirus type 5, E4orf3
  • Adenovirus type 5, L4-100 kDa
  • Ago 1
  • Ago 2
  • APRIL
  • APRIL-Phosphothreonin 224
  • Blocking, FC gamma receptor, mouse, several isotypes
  • Bop1 (human, block of proliferation)
  • Borna gp18
  • Borna p24
  • Borna p40
  • Borna p56
  • BRD7, human, cellular
  • C-24
  • C-Myc, N-term
  • C1q, C3, C4, mouse
  • C1q, human
  • Calcitonin
  • Canine, CD44
  • CBF1 (CSL, Su(H), RBP-1)
  • CCR9
  • CD154, human, monkey
  • CD155
  • CD3 epsilon chain
  • CD4, mouse
  • CD44, canine
  • CD49c
  • CD8, mouse
  • CD83, human
  • CD96
  • Cdc45 cell division cycle 45p
  • CDs, several, dog
  • CDs, several, dog
  • Cellular, BRD7, human
  • Chicken, GTP cyclohydrolase
  • Chicken, Interferon -γ
  • Chicken, Interferon, alpha
  • Chimerin
  • CNG channel alpha3, rat
  • CNG channel, cone type, rat
  • Contactin1, mouse/chicken, mouse monoclonal
  • Cyclodextrinase, Klebsiella oxytoca
  • Cythohesin-1
  • CYTIP
  • Cytomegalievirus, glycoprotein gp40
  • Dead box protein, DP103
  • Dead box protein, DP103
  • DLL1
  • DNA pol delta p125 subunit
  • DNA pol delta p50 subunit
  • dog C1q
  • Dog, several CDs
  • Dog, several CDs
  • DUTPase, EBV
  • dUTPase, human
  • E1B AP5 / HNRPUL1, Ribonucleoprotein hnRNP
  • EBNA-3A
  • EBV, BHRF1
  • EBV, dUTPase
  • EBV, EBNA1
  • EBV, EBNA2, several epitopes
  • EBV, EBNA2, wwp-peptide
  • EBV, EBNA2A, several epitopes
  • EBV, EBNA2b, several epitopes
  • EBV, LMP1, several epitopes
  • EBV, LMP2a, TP, several epitopes
  • EDG
  • ENV, Herv K10
  • ENV, Herv K10
  • ENV, Herv K10
  • Epitopes, several, HIV-2, Nef protein
  • Epsilon chain, Protein kinase C
  • FC gamma receptor, mouse, blocking, several isotypes
  • FITC
  • FLT-1
  • Formin-related protein in leukocytes 1
  • Gag protein, Herv K10
  • GTP cyclohydrolase, chicken
  • GTP cyclohydrolase, human
  • GTP cyclohydrolase, murine
  • Guanylate binding protein GBP-1
  • H2BUb1 (histone2B, ubiquintylated)
  • H3X
  • HCMV, US28
  • Helt
  • Herv K10, ENV
  • Herv K10, ENV
  • Herv K10, ENV
  • Herv K10, gag protein
  • HHV8, Kaposin
  • HHV8, majorcapsid antigen (OFR 25)
  • HHV8, minor capsid antigen (ORF 26)
  • HHV8m, dUTPase
  • Histone H3, K27 dimethylated
  • Histone H4, K20 methylated
  • HIV-2, Nef protein, several epitopes
  • Hmd, Methanothermobacter
  • Hmd, Methanothermobacter
  • HSP72
  • Human cellular, USP7/HAUSP
  • Human origin recognition complex, OCR1 (hsORC)
  • Human origin recognition complex, OCR2 (hsORC)
  • Human origin recognition complex, OCR6 (hsORC)
  • Human origin recognition complexOCR3 (hsORC)
  • Human, C1q
  • Human, CD154, monkey
  • Human, cellular, BRD7
  • Human, GTP cyclohydrolase
  • Human, Importin a1
  • Human, Importin a3
  • Human, Importin a4
  • Human, Importin a5
  • Human, Importin a7
  • Human, Methyltrans-ferase PRMT2
  • Human, Notch1 intracellular, mouse
  • Human, Notch3, intracellular
  • Human, PAX9, murine
  • Human, primase, p58, p48
  • Human, Replication protein A, RPA32
  • Human, Replication protein A, RPA70
  • Hyperpolarization-activated Channel HCN1
  • Hyperpolarization-activated channel HCN2
  • Hyperpolarization-activated channel HCN3
  • Hyperpolarization-activated channel HCN4
  • Id, mouse lymphoma
  • IgG2c, rat
  • Ink4a
  • Interferon alpha, chicken
  • Isotypes, several, FC gamma receptor, mouse, blocking
  • Isotypes, various, murine CD45
  • Jul 1C11
  • K20 methylated, Histone H4
  • Kaposin, HHV8
  • Karyopherin alpha2, Rch1
  • Lambda light chain, rat
  • LARK
  • LARK/RBM4A
  • LCMV-gp44 (Klon 25)
  • Listeria monocytogenes Internalin B, Dhly pfrA 7973
  • Listeria supernatant EDGprfA+
  • Listeria supernatant EDGprfA+
  • Listeria supernatant, complete
  • Listeria supernatant, electro-elualed bands
  • Listeria supernatant, eletro-elualed bands
  • Ly1.1, Mouse anti mouse CD5
  • Ly1.2, Mouse anti mouse CD5
  • Lyt-1, mouse
  • M161Ag
  • MAD1
  • Mage11
  • MBP, maltose-binding protein, rat
  • Methanothermobacter, Hmd
  • Methanothermobacter, Hmd
  • Methyltransferase PRMT2, human
  • Monkey, human, CD154
  • Motifantibody Poly DE
  • Motifantibody Poly PRO
  • Mouse anti mouse CD5, Ly1.1
  • Mouse anti mouse CD5, Ly1.2
  • Mouse anti-MBP, maltose binding protein
  • Mouse anti-TrpE
  • Mouse IRS-2
  • Mouse IRS-2
  • Mouse lymphoma, ld
  • Mouse Lyt-1
  • Mouse, C1q, C3, C4
  • Mouse, CD4
  • Mouse, CD8
  • Mouse, RmT1, RmT2, RmT5, anti-Thy1
  • Mouse, several Isotypes, FC gamma receptor, blocking
  • Mouse, Thy1.2, spleen AKR
  • Mouse, Thy1.2, spleen CBL
  • Murine CD45, various isotypes
  • Murine, GTP cyclohydrolase
  • Murine, PAX9, human
  • N-term, C-Myc
  • NCAM AB – 5A2
  • Nef protein, several epitopes, HIV-2
  • Notch1 intracellular, mouse, human
  • Notch3, intracellular, human
  • OCR1, human origin recognition complex (hsORC)
  • OCR2, human origin recognition complex (hsORC)
  • OCR3, human origin recognition complex (hsORC)
  • OCR6, human origin recognition complex (hsORC)
  • PAX1
  • PAX9, murine, human
  • PAY, PC2 associated Q-rich protein
  • PCNA
  • Pes1 (human, pescadillo, rRNA processing factor)
  • PF1
  • PF63.1
  • Pirin
  • PP32
  • Primase, p58, p48, human
  • Protein kinase C, epsilon chain
  • Protein kinase C, zeta chain
  • Protein phosphatase 2A
  • Rat anti-GST, synergistic to M-GST
  • Rat anti-trpE
  • Rat IgG2c
  • Rat, lambda light chain
  • Rat, MBP, maltose-binding protein
  • RBM4A
  • RBM4B
  • RBM4B
  • RBP (CBF1)
  • Rch1, Karyopherin alpha2
  • Replication protein A, RPA14
  • Replication protein A, RPA32, human
  • Replication protein A, RPA70, human
  • Ribonucleoprotein hnRNP, E1B AP5 / HNRPUL1
  • RISP
  • RmT1, RmT2, RmT5, anti-Thy1, mouse
  • RNA Polymerase II - CTD (non-phosporylated)
  • RNA Polymerase II - CTD-Ser2-P
  • RNA Polymerase II - CTD-Ser5-P
  • RNA Polymerase II - CTD-Ser7-P
  • RNA Polymerase II - CTD-Thr4-P
  • RNA Polymerase II - CTD-Tyr1-P
  • Sepiapterin reductase
  • SH2D1A (X-linked lymphoproliferative disease XLP)
  • TCR
  • Tenascin-R
  • Thy1.2, mouse, spleen AKR
  • Thy1.2, mouse, spleen CBL
  • TMEM59
  • TRAF1
  • TRAF2
  • Transcription Cofactor NC2 alpha
  • TrpE, Rat
  • US28, HCMV
  • USP7/HAUSP, human cellular
  • UTP18 (human, rRNA processing factor)
  • VIII41, ZBP-89
  • WDR12 (WD-repeat 12, rRNA processing factor)
  • wwp-peptide, EBV, EBNA2
  • Yku70, yeast
  • Zeta chain, Protein kinase C
   Clear all

Cardiovascular

  • Ref-No.Technology
  • 03-00230Modulation of ß-Catenin signalling for the treatment of cardiovascular diseases
  • 03-00303RBM20 as a diagnostic marker for cardiovascular diseases
  • 03-00319Stimulation of arteriogenesis for the prevention of myocardial infarction
  • 03-00341KCNQ4 and KCNQ5 ion channels for the identification of selective channel function modulators
  • 03-00389Volume-regulated anion channel VRAC as a target in drug discovery
  • 03-00393Novel TPH inhibitors for the treatment of fibrotic diseases and pulmonary arterial hypertension (PAH)
  • 15-00337Circulating microRNAs for diagnosis of Takotsubo-Cardiomyopathy
  • 15-00371lncRNAs in therapy and diagnosis of disease related angiogenesis
  • 15-00411Novel diagnostic for Peripartum cardiomyopathy (PPCM) in pregnant women
  • 15-00551In vitro produced cardiac organoids as a novel tool for pharmacological research.
  • 32-00049Preventing Vascular Calcification in Chronic Kidney Disease
  • 32-00052Non-invasive cardiac pressure determination
  • 43-00012Human blood vessel organoids for disease modelling and drug screening
  • 44-00001Technology enabling a comprehensive analysis of blood flow in vessels
  • 99-00126Novel gene therapy approach for cardiovascular diseases
   Clear all

CNS

  • Ref-No.Technology
  • 01-00903Novel method for direct neuronal reprogramming
  • 01-00987DMD Gene Therapy Approach
  • 03-00128New Key Drug Target for Psychiatric Disorders
  • 03-00317Novel inhibitors of amyloid aggregate formation
  • 03-00341KCNQ4 and KCNQ5 ion channels for the identification of selective channel function modulators
  • 03-00363Small molecule inhibitors of STOML3 promise to treat neuropathic pain
  • 03-00367Targeting of Autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in Alzheimer’s and vascular dementia
  • 10-00107Barnesins – novel natural small molecules as highly specific cysteine protease inhibitors
  • 11-00057Innovative Nerve Sheath Tumor Therapy
  • 15-00006Biocompatible nerve guidance conduit for neuroregeneration
  • 15-00247Methylation biomarker to predict the response to monoaminergic antidepressants
  • 15-00603Endoscopic device for stimulation of the laryngeal adductor reflex
  • 16-00012SUCLG2 as determinator of CSF Aβ1-42 levels and attenuator of cognitive decline in Alzheimer’s disease
  • 21-00002SynProt-A database for the proteome of synaptic junctions
  • 21-00011Innovative diagnostic agent for high resolution mapping of acute cerebral ischemia
  • 21-00022Novel device for minimally-invasive optical stimulation of nerve cells
  • 21-00027Ferulic acid derivative FAE-20 as efficient neuroprotective agent and memory enhancer
  • 23-00054Reduction of α-synuclein toxicity using PDE-1 inhibitor as a novel treatment in neurodegenerative synucleinopathies
  • 23-00064Treating dementia and other brain disorders with natural glycans
  • 23-00065Novel treatment of dementia-associated tauopathies
  • 23-00069NMDAR targeted CAAR-T cell therapy
  • 24-00004PET-tracer for early diagnosis of Alzheimer's disease
  • 43-00006Genetically engineered human 3D brain tumor models for disease modeling and compound evaluation
   Clear all

Dermatology

  • Ref-No.Technology
  • 01-00970Skin Tissue Model “SCAR-In-A-Dish”
  • 03-00363Small molecule inhibitors of STOML3 promise to treat neuropathic pain
  • 14-00097Anti-inflammatory, anti-bacterial agent for treatment of Atopic Dermatitis
  • 14-00097Antimicrobial, endotoxine-neutralizing and anti-inflammatory agent for wound healing and treatment of bacterial skin and soft-tissue infections
   Clear all

Diagnostics

  • Ref-No.Technology
  • 01-00890Multiplexed Targeted Barcoding Technology for NGS Applications
  • 01-00897Lateral flow immunoassay with covalently clustered particles for enhanced sensitivity
  • 01-00967Novel optoacoustic endoscope for diagnostic purposes
  • 01-00971Optoacoustic chemical microscopy
  • 01-00976NMR glass capillary sealing device
  • 02-00324Innovative DOTA-Linkers for Bacterial Targeting
  • 02-00328Determination of Biofilm Dynamics via Impedance
  • 02-00336Profiling of antimicrobial susceptibility and phylogenetic relations
  • 02-00351Increased Availability and Efficacy of Aminoglycosides
  • 02-00353High-throughput Screening for anti-herpesviridae Drugs
  • 03-00245Intracellular Target for Systemic Lupus Erythematodes (SLE)
  • 03-00302Aptamers for Treatment and Diagnosis of Autoantibody-based dilated Cardiomyopathy
  • 03-00303RBM20 as a diagnostic marker for cardiovascular diseases
  • 03-00305Sensitive PCR-based Biomarker for Identification of Residual Hodgkin Lymphoma Cells
  • 03-00324Novel biomarkers for early diagnosis of Acute Kidney Injury
  • 03-00341KCNQ4 and KCNQ5 ion channels for the identification of selective channel function modulators
  • 03-00359mRNA interactome capture
  • 03-00367Targeting of Autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in Alzheimer’s and vascular dementia
  • 03-00459Autofocus-control of a microscope including an electrically tunable lens
  • 03-00462SPACE-Seq: Localizing Spatial Gene Expression on Single-Cell Level
  • 03-00470FLAM-Seq: Genome-wide full-length mRNA and poly(A)-tail sequencing
  • 05-00033New Candidate Gene for Diagnostic and Therapeutic Development to Combat Obesity-associated Diabetes
  • 14-00013MAdL monoclonal antibody: A novel, highly specific and sensitive biomarker for adenocarcinomas of the lung
  • 14-00022Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
  • 15-00150Semaphorin 5A as potential biomarker for graft vs. host disease
  • 15-00171Prediction and therapy control of large vessel vasculitis
  • 15-00178Diagnostic and prognostic microRNA biomarkers for acute kidney injury
  • 15-00247Methylation biomarker to predict the response to monoaminergic antidepressants
  • 15-00281Diagnostic for Chronic Regional Pain Syndrome (CRPS)
  • 15-00337Circulating microRNAs for diagnosis of Takotsubo-Cardiomyopathy
  • 15-00371lncRNAs in therapy and diagnosis of disease related angiogenesis
  • 15-00386lncRNA TapSaki predicts outcome in patients with Acute Kidney Injury
  • 15-00411Novel diagnostic for Peripartum cardiomyopathy (PPCM) in pregnant women
  • 15-00420Improved method of quantitative magnetic resonance lung imaging using ventilation-weighted Fourier decomposition
  • 15-00502Predicting the therapeutic effect of BH3 mimetics
  • 15-00523Novel Diagnostic for Hepatitis
  • 15-00565Time-efficient assessment of pulmonary function via CT with low radiation doses
  • 21-00011Innovative diagnostic agent for high resolution mapping of acute cerebral ischemia
  • 24-00004PET-tracer for early diagnosis of Alzheimer's disease
  • 24-00011Doped semiconductor substrates for lab on chip systems
  • 24-00015Functionalized silicon nanoparticles for theranostic applications
  • 32-00052Non-invasive cardiac pressure determination
  • 32-00056Non-invasive measurement of myocardial power
  • 42-00007Circulating miR-122 as a biomarker to predict risk of metabolic diseases
  • 42-00019Novel marker-free selection strategy for site-directed homologous recombination targeting the pyrimidine salvage pathway
  • 42-00022Stabilized minigastrin analogs for enhanced CCK2R targeting and applications in neuroendocrine tumor therapeutics and diagnostics
  • 43-00003Highly Improved Reprogramming Efficiency for iPS Cell Generation
  • 44-00001Technology enabling a comprehensive analysis of blood flow in vessels
   Clear all

Drug Delivery

  • Ref-No.Technology
  • 02-00324Innovative DOTA-Linkers for Bacterial Targeting
  • 02-00351Increased Availability and Efficacy of Aminoglycosides
  • 02-00376Overcoming resistance - Innovative broad-spectrum inhibitors of Metallo- β-lactamases
  • 07-00049JC virus-like particles based on VP1: an effective gene-therapeutic and retargeting delivery system
  • 15-00241Method for coating of solid phase substrates and lipid surfaces with a lattice-like clathrin structure
  • 32-00064Novel biomembranes based on defined electro-spun Poly (alkyl Cyanoacrylate)-fibers
  • 99-00075DNA hydrogels from linear building blocks
   Clear all

Gastroenterology

  • Ref-No.Technology
  • 01-00967Novel optoacoustic endoscope for diagnostic purposes
  • 03-00295Highly Effective, Innovative Treatment of Acute Liver Failure
  • 03-00380Negative regulation of the IKK/NF-kB pathway activity by stabilisation of A20 mRNA – a new approach to treat inflammation
  • 03-00393Novel TPH inhibitors for the treatment of fibrotic diseases and pulmonary arterial hypertension (PAH)
  • 15-00436MicroRNA-125b-5p – a new treatment option for drug induced Acute Liver Failure
  • 15-00523Novel Diagnostic for Hepatitis
   Clear all

Green Biotech

  • Ref-No.Technology
  • 06-00002Plant Virus Resistance
  • 06-00059Epidermis-specific pathogen-inducible promoter for cereals
  • 10-00106Gramibactin - A Novel Bifunctional Siderophore-NO-Donor for application in agriculture
  • 42-00019Novel marker-free selection strategy for site-directed homologous recombination targeting the pyrimidine salvage pathway
  • 99-00108Triggering of plant immunity through bacterial hydroxy fatty acid metabolites
   Clear all

Immunology/Autoimmune

  • Ref-No.Technology
  • 01-00937Empowering T and NK cells for adoptive cell transfer (ACT) through engineering with PD-1:4-1BB
  • 02-00330Mouse models for liver immunity and therapeutic vaccinations
  • 03-00207bNovel Peptide Drug enhancing Immune Response in Patients suffering from Immune Suppression and Leukopenia
  • 03-00245Intracellular Target for Systemic Lupus Erythematodes (SLE)
  • 03-00291Multiple Target T Cell Receptor
  • 03-00380Negative regulation of the IKK/NF-kB pathway activity by stabilisation of A20 mRNA – a new approach to treat inflammation
  • 03-00397Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
  • 03-00399/32-00019Human satellite cells as cell therapy for the treatment of muscle waisting disorders
  • 03-00417Novel BCMA-CAR for the treatment of multiple myeloma and non-Hodgkin lymphoma (NHL)
  • 14-00097Anti-inflammatory, anti-bacterial agent for treatment of Atopic Dermatitis
  • 14-00097Antimicrobial, endotoxine-neutralizing and anti-inflammatory agent for wound healing and treatment of bacterial skin and soft-tissue infections
  • 15-00150Semaphorin 5A as potential biomarker for graft vs. host disease
  • 15-00171Prediction and therapy control of large vessel vasculitis
  • 15-00379Mutation leading to Type 1 Diabetes mellitus and corresponding animal model
  • 15-00461Novel treatment for septic diseases in newborns
  • 15-00523Novel Diagnostic for Hepatitis
  • 22-00009Quiescent B Cells for immune suppression in gene therapy
  • 22-00017Functional IFN-gamma memory in CD4+ T cells: Method for improved T cell therapy and disease monitoring in autoimmune diseases
  • 22-00020Bispecific antibodies for cell-type-specific TNF inhibition
  • 23-00069NMDAR targeted CAAR-T cell therapy
  • 32-00049Preventing Vascular Calcification in Chronic Kidney Disease
  • 42-00022Stabilized minigastrin analogs for enhanced CCK2R targeting and applications in neuroendocrine tumor therapeutics and diagnostics
   Clear all

Infectious Diseases

  • Ref-No.Technology
  • 01-00758Generation of EBV-specific T-cells using virus-like particles facilitates adoptive treatment of EBV-associated diseases
  • 01-00833VLP-based Epstein-Barr-Virus (EBV) vaccine
  • 01-00897Lateral flow immunoassay with covalently clustered particles for enhanced sensitivity
  • 01-00937Empowering T and NK cells for adoptive cell transfer (ACT) through engineering with PD-1:4-1BB
  • 01-EBV-VLPA VLP-based prophylactic EBV vaccine
  • 02-00226Inhibition of Pathogenic Biofilms on natural or synthetic surfaces
  • 02-00278High-throughput test system for bacterial biofilms
  • 02-00303Novel Myxopyronin Analogues and Myxopyronin Genecluster for Mutasynthesis
  • 02-00311Cystobactamides – novel antibacterials against gram-negative pathogens
  • 02-00312Novel Macrolide Antibiotics
  • 02-00315Novel Chelocardin Derivatives – resistance breaking atypical tetracyclines with broad-spectrum antibiotic activity
  • 02-00316Innovative Inhibitors of Pseudomonas Pathogenicity
  • 02-00324Innovative DOTA-Linkers for Bacterial Targeting
  • 02-00328Determination of Biofilm Dynamics via Impedance
  • 02-00332Novel inhibitors of Pseudomonas aeruginosa LecB
  • 02-00336Profiling of antimicrobial susceptibility and phylogenetic relations
  • 02-00337Novel labyrinthopeptins as anti-viral agents
  • 02-00351Increased Availability and Efficacy of Aminoglycosides
  • 02-00353High-throughput Screening for anti-herpesviridae Drugs
  • 02-00354Highly active Chlorotonil A Derivatives for the treatment of Malaria
  • 02-00368Bivalent LecA Inhibitors Targeting Biofilm Formation of Pseudomonas aeruginosa
  • 02-00376Overcoming resistance - Innovative broad-spectrum inhibitors of Metallo- β-lactamases
  • 03-00295Highly Effective, Innovative Treatment of Acute Liver Failure
  • 10-00026Novel Benzothiazinones, potent Tuberculosis antibiotics
  • 10-00080Closthioamide- a new, unusual natural product with potent antibiotic activity against MRSA
  • 10-00087Jagaricin – a novel antifungal natural compound
  • 10-00088Bixiamycines –novel natural compounds with broad-spectrum antibiotic activity
  • 10-00092Clostrubin - an unusual novel polyketide antibiotic
  • 10-00107Barnesins – novel natural small molecules as highly specific cysteine protease inhibitors
  • 14-00020Anti-inflammatory, LPS-neutralizing and anti-bacterial agent against sepsis and other severe bacterial infections
  • 14-00020bSALP peptides are potent broad-spectrum anti-viral agents
  • 14-00097Anti-inflammatory, anti-bacterial agent for treatment of Atopic Dermatitis
  • 14-00097Antimicrobial, endotoxine-neutralizing and anti-inflammatory agent for wound healing and treatment of bacterial skin and soft-tissue infections
  • 14-00098Targeting host lipid homeostasis to augment anti-mycobacterial treatment
  • 15-00432Scalable and Continuous Production of iPSC-derived Macrophages for Therapeutic and Research Applications
  • 15-00461Novel treatment for septic diseases in newborns
  • 18-00021Use of cPLA2a-Inhibitors in therapy of flavivirus infection
  • 22-00020Bispecific antibodies for cell-type-specific TNF inhibition
   Clear all

Medical Devices

  • Ref-No.Technology
  • 01-00967Novel optoacoustic endoscope for diagnostic purposes
  • 01-00971Optoacoustic chemical microscopy
  • 03-00459Autofocus-control of a microscope including an electrically tunable lens
  • 15-00091Optical Cochlea Stimulator
  • 15-00096Laser Hearing Aid
  • 15-00199The “i-scoop” – a new type of laryngoscope for normal and difficult airways
  • 15-00343Automatic 3D modelling of craniofacial bone defects
  • 15-00384Pre-sterilized modular surgical guidance device
  • 15-00420Improved method of quantitative magnetic resonance lung imaging using ventilation-weighted Fourier decomposition
  • 15-00490Irradiation device and method for optical cochlear implants and laser surgery sytems
  • 15-00553Magnetic Artificial Shoulder Joint
  • 15-00565Time-efficient assessment of pulmonary function via CT with low radiation doses
  • 15-00603Endoscopic device for stimulation of the laryngeal adductor reflex
  • 21-00003High-resolution multiwire electrode for chronic implantation in rodents
  • 21-00019Microelectrode array with combined optical stimulation
  • 24-00011Doped semiconductor substrates for lab on chip systems
  • 32-00030Method and arrangement for identification and correction of optical aberrations
  • 32-00048Adapter for inserting a dental implant
  • 32-00052Non-invasive cardiac pressure determination
  • 32-00056Non-invasive measurement of myocardial power
  • 32-00058Blood transfusion safety system Cairos
  • 32-00064Novel biomembranes based on defined electro-spun Poly (alkyl Cyanoacrylate)-fibers
  • 44-00001Technology enabling a comprehensive analysis of blood flow in vessels
  • 99-00075DNA hydrogels from linear building blocks
   Clear all

Metabolic Diseases

  • Ref-No.Technology
  • 01-00901Marker for beta-cell maturation
  • 03-00248Use of MAS-G-Protein-coupled receptor agonists for the treatment of Metabolic Syndrome
  • 03-00393Novel TPH inhibitors for the treatment of fibrotic diseases and pulmonary arterial hypertension (PAH)
  • 05-00033New Candidate Gene for Diagnostic and Therapeutic Development to Combat Obesity-associated Diabetes
  • 14-00022Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
  • 15-00379Mutation leading to Type 1 Diabetes mellitus and corresponding animal model
  • 32-00049Preventing Vascular Calcification in Chronic Kidney Disease
  • 42-00007Circulating miR-122 as a biomarker to predict risk of metabolic diseases
  • 43-00012Human blood vessel organoids for disease modelling and drug screening
   Clear all

Oncology

  • Ref-No.Technology
  • 01-00830Novel antibody to carbonic anhydrase XII with therapeutic and diagnostic potential for solid tumors and eye diseases
  • 01-00937Empowering T and NK cells for adoptive cell transfer (ACT) through engineering with PD-1:4-1BB
  • 02-00187Argyrin – A promising novel anti-cancer compound
  • 02-00297Treatment of hepatocellular carcinoma
  • 02-00350Novel Ratjadones as payloads in folate-, peptide-, and antibody-drug conjugates for the treatment of cancer
  • 02-00352Carolacton as MTHFD2 inhibitor for cancer therapy
  • 03-00239Epitope-Tag for surface-expressed T cell receptor (TCR) for administration of ex vivo modified cells
  • 03-00305Sensitive PCR-based Biomarker for Identification of Residual Hodgkin Lymphoma Cells
  • 03-00352Repurposing Niclosamide for (neo-)adjuvant cancer therapy
  • 03-00389Volume-regulated anion channel VRAC as a target in drug discovery
  • 03-00397Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
  • 03-00413Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
  • 03-00417Novel BCMA-CAR for the treatment of multiple myeloma and non-Hodgkin lymphoma (NHL)
  • 03-00430Selective Inhibitors of Genotoxic Stress-Induced IKK/NF-κB Pathways for Cancer Therapy
  • 10-00107Barnesins – novel natural small molecules as highly specific cysteine protease inhibitors
  • 11-00054Innovative inhibitors of Notch trafficking and signalling for the treatment of cancer
  • 11-00057Innovative Nerve Sheath Tumor Therapy
  • 14-00013MAdL monoclonal antibody: A novel, highly specific and sensitive biomarker for adenocarcinomas of the lung
  • 15-00302Novel inhibitor of mutated IDH1 in cancer therapy
  • 15-00358COAT – an exceptionally efficient tumor vaccination approach
  • 15-00371lncRNAs in therapy and diagnosis of disease related angiogenesis
  • 15-00394Efficient oncolytic anti-tumor therapy based on adenovirus
  • 15-00502Predicting the therapeutic effect of BH3 mimetics
  • 22-00017Functional IFN-gamma memory in CD4+ T cells: Method for improved T cell therapy and disease monitoring in autoimmune diseases
  • 24-00015Functionalized silicon nanoparticles for theranostic applications
  • 32-00059T-cell therapy of MYD88L265P-dependent B-cell lymphoma
  • 42-00022Stabilized minigastrin analogs for enhanced CCK2R targeting and applications in neuroendocrine tumor therapeutics and diagnostics
  • 43-00006Genetically engineered human 3D brain tumor models for disease modeling and compound evaluation
  • 43-00012Human blood vessel organoids for disease modelling and drug screening
   Clear all

Other Indications

  • Ref-No.Technology
  • 01-00903Novel method for direct neuronal reprogramming
  • 03-00092Substances modulating primary haemostasis
  • 03-00341KCNQ4 and KCNQ5 ion channels for the identification of selective channel function modulators
  • 03-00389Volume-regulated anion channel VRAC as a target in drug discovery
  • 03-00399/32-00019Human satellite cells as cell therapy for the treatment of muscle waisting disorders
  • 03-00400Novel method for isolation and cultivation of ground state cells from heterogenous human pluripotent stem cell cultures
  • 03-00413Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
  • 10-00107Barnesins – novel natural small molecules as highly specific cysteine protease inhibitors
  • 11-00060Novel treatment or prevention of age-related diseases extending lifespan
  • 15-00044Enabling selective myosin-inhibitor development
  • 15-00154Novel method for serum-free generation of respiratory epithelial cells
  • 15-00241Method for coating of solid phase substrates and lipid surfaces with a lattice-like clathrin structure
  • 15-00358COAT – an exceptionally efficient tumor vaccination approach
  • 15-00565Time-efficient assessment of pulmonary function via CT with low radiation doses
  • 32-00030Method and arrangement for identification and correction of optical aberrations
  • 32-00064Novel biomembranes based on defined electro-spun Poly (alkyl Cyanoacrylate)-fibers
  • 42-00019Novel marker-free selection strategy for site-directed homologous recombination targeting the pyrimidine salvage pathway
   Clear all

Research Tools

  • Ref-No.Technology
  • 01-00366Human Voxel Models
  • 01-00890Multiplexed Targeted Barcoding Technology for NGS Applications
  • 01-00901Marker for beta-cell maturation
  • 01-00903Novel method for direct neuronal reprogramming
  • 01-00940Mammary organoids derived from primary human breast epithelial cells
  • 01-00970Skin Tissue Model “SCAR-In-A-Dish”
  • 01-00971Optoacoustic chemical microscopy
  • 01-00976NMR glass capillary sealing device
  • 02-00116New viral packaging cell line
  • 02-00336Profiling of antimicrobial susceptibility and phylogenetic relations
  • 02-00353High-throughput Screening for anti-herpesviridae Drugs
  • 03-00125Frog Prince: A Highly Active Transposon System For Insertional Mutagenesis, Gene-Trapping, and Gene Transfer in Vertebrates
  • 03-00128New Key Drug Target for Psychiatric Disorders
  • 03-00219Gene therapy protein expression technology
  • 03-00251Stable Gene Transfer with Hyperactive Sleeping Beauty Transposase SB100X
  • 03-00341KCNQ4 and KCNQ5 ion channels for the identification of selective channel function modulators
  • 03-00359mRNA interactome capture
  • 03-00389Volume-regulated anion channel VRAC as a target in drug discovery
  • 03-00390Genome Architecture Mapping
  • 03-00399/32-00019Human satellite cells as cell therapy for the treatment of muscle waisting disorders
  • 03-00400Novel method for isolation and cultivation of ground state cells from heterogenous human pluripotent stem cell cultures
  • 03-00413Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
  • 03-00453Homology Independent Genomic Sequence Replacement
  • 03-00459Autofocus-control of a microscope including an electrically tunable lens
  • 03-00461Identifying Cellular States and Fate Transitions via Synthetic Locus Control Regions (sLCRs)
  • 03-00462SPACE-Seq: Localizing Spatial Gene Expression on Single-Cell Level
  • 03-00470FLAM-Seq: Genome-wide full-length mRNA and poly(A)-tail sequencing
  • 07-00049JC virus-like particles based on VP1: an effective gene-therapeutic and retargeting delivery system
  • 07-00080Innovative plasmids and cells for SARS-CoV-2-specific research
  • 11-00035Cell wall-less bacteria (L-forms) for high yield heterologous protein expression
  • 11-00053High quality tubulin and microtubule-associated proteins: tau, MAP1 and MAP2 as research tools
  • 14-00004High-throughput assay for screening the stability of peptide drugs in proteolytic environments
  • 14-00013MAdL monoclonal antibody: A novel, highly specific and sensitive biomarker for adenocarcinomas of the lung
  • 14-00022Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
  • 14-00073Improved endotoxin test for the quality control of biologics, overcoming low endotoxin recovery (LER) / low lipopolysaccharide recovery (LLR) phenomenon
  • 15-00044Enabling selective myosin-inhibitor development
  • 15-00420Improved method of quantitative magnetic resonance lung imaging using ventilation-weighted Fourier decomposition
  • 15-00432Scalable and Continuous Production of iPSC-derived Macrophages for Therapeutic and Research Applications
  • 15-00551In vitro produced cardiac organoids as a novel tool for pharmacological research.
  • 21-00002SynProt-A database for the proteome of synaptic junctions
  • 21-00022Novel device for minimally-invasive optical stimulation of nerve cells
  • 22-00022Gene List Significance Index
  • 24-00004PET-tracer for early diagnosis of Alzheimer's disease
  • 24-00011Doped semiconductor substrates for lab on chip systems
  • 24-00015Functionalized silicon nanoparticles for theranostic applications
  • 24-00027DNA encircled bilayers (DEB) for the study of membrane proteins
  • 32-00030Method and arrangement for identification and correction of optical aberrations
  • 43-00003Highly Improved Reprogramming Efficiency for iPS Cell Generation
  • 43-00004CRISPR Switch: Inducible sgRNA expression for tightly regulated, efficient & safer CRISPR/Cas9 genome editing
  • 43-00006Genetically engineered human 3D brain tumor models for disease modeling and compound evaluation
  • 43-00012Human blood vessel organoids for disease modelling and drug screening
  • 99-00075DNA hydrogels from linear building blocks
   Clear all

Software

  • Ref-No.Technology
  • 01-00366Human Voxel Models
  • 03-00431CrispRGold - Design of efficient Crispr/Cas sgRNA sequences
  • 11-00052KILAPE – Automated scaffolding and gap filling of large, complex genomes
  • 15-00420Improved method of quantitative magnetic resonance lung imaging using ventilation-weighted Fourier decomposition
  • 15-00565Time-efficient assessment of pulmonary function via CT with low radiation doses
  • 22-00022Gene List Significance Index
  • 32-00056Non-invasive measurement of myocardial power
  • 32-00058Blood transfusion safety system Cairos
   Clear all

Vaccines

  • Ref-No.Technology
  • 01-00758Generation of EBV-specific T-cells using virus-like particles facilitates adoptive treatment of EBV-associated diseases
  • 01-00833VLP-based Epstein-Barr-Virus (EBV) vaccine
  • 01-EBV-VLPA VLP-based prophylactic EBV vaccine
  • 02-00116New viral packaging cell line
  • 02-00158Cyclic di-Nucleotides as adjuvants
  • 02-00160Hexosylceramides as adjuvants
  • 02-00280Innovative lipopeptide-conjugates as mucosal adjuvants - BPPcysPep-MPEG
  • 02-00361Cyclic-di-AMP: a promising adjuvant for neonatal vaccines
  • 03-00207aNovel adjuvant class for use in immunotherapy and vaccination.
  • 15-00358COAT – an exceptionally efficient tumor vaccination approach
  • 15-00377Fast and Efficient Method for Chemoenzymatic Production of Neisseria meningitidis Glycoconjugate Vaccines
  • 15-00527New Class of Bacterial Capsule Polymerases for Cost-Effective Synthesis of Glycoconjugate Vaccines
   Clear all

Chemical Catalyst

  • Ref-No.Technology
  • 10-00105Biaryl coupling by Photosplicing
  • 28-00019Inexpensive and highly efficient catalysts for the production of propene and related light olefins
  • 28-00021Powerful and versatile catalysts for efficient and sustainable production of a wide range of cyclic organic carbonates from a broad range of internal and external epoxides
  • 28-00021 (2)Efficient synthesis of even challenging (i.e. silyl-functionalized, fluorinated or bicyclic) cyclic organic carbonates under mild conditions e.g. for improved coatings, electrolytes and/or non-isocyanate polyurethanes
   Clear all

Chemical Synthesis

  • Ref-No.Technology
  • 10-00105Biaryl coupling by Photosplicing
  • 28-00019Inexpensive and highly efficient catalysts for the production of propene and related light olefins
  • 28-00021Powerful and versatile catalysts for efficient and sustainable production of a wide range of cyclic organic carbonates from a broad range of internal and external epoxides
  • 28-00021 (2)Efficient synthesis of even challenging (i.e. silyl-functionalized, fluorinated or bicyclic) cyclic organic carbonates under mild conditions e.g. for improved coatings, electrolytes and/or non-isocyanate polyurethanes
   Clear all

Therapeutics

  • Ref-No.Technology
  • 01-00758Generation of EBV-specific T-cells using virus-like particles facilitates adoptive treatment of EBV-associated diseases
  • 01-00830Novel antibody to carbonic anhydrase XII with therapeutic and diagnostic potential for solid tumors and eye diseases
  • 01-00833VLP-based Epstein-Barr-Virus (EBV) vaccine
  • 01-00937Empowering T and NK cells for adoptive cell transfer (ACT) through engineering with PD-1:4-1BB
  • 01-00987DMD Gene Therapy Approach
  • 01-EBV-VLPA VLP-based prophylactic EBV vaccine
  • 02-00187Argyrin – A promising novel anti-cancer compound
  • 02-00226Inhibition of Pathogenic Biofilms on natural or synthetic surfaces
  • 02-00297Treatment of hepatocellular carcinoma
  • 02-00311Cystobactamides – novel antibacterials against gram-negative pathogens
  • 02-00312Novel Macrolide Antibiotics
  • 02-00315Novel Chelocardin Derivatives – resistance breaking atypical tetracyclines with broad-spectrum antibiotic activity
  • 02-00316Innovative Inhibitors of Pseudomonas Pathogenicity
  • 02-00332Novel inhibitors of Pseudomonas aeruginosa LecB
  • 02-00337Novel labyrinthopeptins as anti-viral agents
  • 02-00350Novel Ratjadones as payloads in folate-, peptide-, and antibody-drug conjugates for the treatment of cancer
  • 02-00351Increased Availability and Efficacy of Aminoglycosides
  • 02-00352Carolacton as MTHFD2 inhibitor for cancer therapy
  • 02-00353High-throughput Screening for anti-herpesviridae Drugs
  • 02-00354Highly active Chlorotonil A Derivatives for the treatment of Malaria
  • 02-00368Bivalent LecA Inhibitors Targeting Biofilm Formation of Pseudomonas aeruginosa
  • 02-00376Overcoming resistance - Innovative broad-spectrum inhibitors of Metallo- β-lactamases
  • 03-00092Substances modulating primary haemostasis
  • 03-00207aNovel adjuvant class for use in immunotherapy and vaccination.
  • 03-00207bNovel Peptide Drug enhancing Immune Response in Patients suffering from Immune Suppression and Leukopenia
  • 03-00248Use of MAS-G-Protein-coupled receptor agonists for the treatment of Metabolic Syndrome
  • 03-00251Stable Gene Transfer with Hyperactive Sleeping Beauty Transposase SB100X
  • 03-00291Multiple Target T Cell Receptor
  • 03-00295Highly Effective, Innovative Treatment of Acute Liver Failure
  • 03-00302Aptamers for Treatment and Diagnosis of Autoantibody-based dilated Cardiomyopathy
  • 03-00317Novel inhibitors of amyloid aggregate formation
  • 03-00319Stimulation of arteriogenesis for the prevention of myocardial infarction
  • 03-00352Repurposing Niclosamide for (neo-)adjuvant cancer therapy
  • 03-00363Small molecule inhibitors of STOML3 promise to treat neuropathic pain
  • 03-00367Targeting of Autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in Alzheimer’s and vascular dementia
  • 03-00380Negative regulation of the IKK/NF-kB pathway activity by stabilisation of A20 mRNA – a new approach to treat inflammation
  • 03-00393Novel TPH inhibitors for the treatment of fibrotic diseases and pulmonary arterial hypertension (PAH)
  • 03-00397Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
  • 03-00399/32-00019Human satellite cells as cell therapy for the treatment of muscle waisting disorders
  • 03-00413Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
  • 03-00417Novel BCMA-CAR for the treatment of multiple myeloma and non-Hodgkin lymphoma (NHL)
  • 03-00430Selective Inhibitors of Genotoxic Stress-Induced IKK/NF-κB Pathways for Cancer Therapy
  • 03-00446Novel CAR-T against CXCR5 for treatment of non-Hodgkin lymphoma
  • 10-00026Novel Benzothiazinones, potent Tuberculosis antibiotics
  • 10-00080Closthioamide- a new, unusual natural product with potent antibiotic activity against MRSA
  • 10-00087Jagaricin – a novel antifungal natural compound
  • 10-00088Bixiamycines –novel natural compounds with broad-spectrum antibiotic activity
  • 10-00092Clostrubin - an unusual novel polyketide antibiotic
  • 11-00054Innovative inhibitors of Notch trafficking and signalling for the treatment of cancer
  • 11-00057Innovative Nerve Sheath Tumor Therapy
  • 11-00060Novel treatment or prevention of age-related diseases extending lifespan
  • 14-00020Anti-inflammatory, LPS-neutralizing and anti-bacterial agent against sepsis and other severe bacterial infections
  • 14-00020bSALP peptides are potent broad-spectrum anti-viral agents
  • 14-00097Antimicrobial, endotoxine-neutralizing and anti-inflammatory agent for wound healing and treatment of bacterial skin and soft-tissue infections
  • 15-00302Novel inhibitor of mutated IDH1 in cancer therapy
  • 15-00358COAT – an exceptionally efficient tumor vaccination approach
  • 15-00371lncRNAs in therapy and diagnosis of disease related angiogenesis
  • 15-00385LNCRNAS GADLOR 1 + 2 FOR DIAGNOSIS AND TREATMENT OF CARDIAC HYPERTROPHY
  • 15-00394Efficient oncolytic anti-tumor therapy based on adenovirus
  • 15-00432Scalable and Continuous Production of iPSC-derived Macrophages for Therapeutic and Research Applications
  • 15-00436MicroRNA-125b-5p – a new treatment option for drug induced Acute Liver Failure
  • 15-00461Novel treatment for septic diseases in newborns
  • 18-00021Use of cPLA2a-Inhibitors in therapy of flavivirus infection
  • 21-00027Ferulic acid derivative FAE-20 as efficient neuroprotective agent and memory enhancer
  • 22-00009Quiescent B Cells for immune suppression in gene therapy
  • 22-00017Functional IFN-gamma memory in CD4+ T cells: Method for improved T cell therapy and disease monitoring in autoimmune diseases
  • 22-00020Bispecific antibodies for cell-type-specific TNF inhibition
  • 23-00064Treating dementia and other brain disorders with natural glycans
  • 23-00065Novel treatment of dementia-associated tauopathies
  • 23-00069NMDAR targeted CAAR-T cell therapy
  • 23-00080Neutralizing Antibodies for Treatment of COVID19 Infection
  • 32-00059T-cell therapy of MYD88L265P-dependent B-cell lymphoma
  • 42-00022Stabilized minigastrin analogs for enhanced CCK2R targeting and applications in neuroendocrine tumor therapeutics and diagnostics
  • 99-00126Novel gene therapy approach for cardiovascular diseases
   Clear all

Technical Equipment

  • Ref-No.Technology
  • 01-00971Optoacoustic chemical microscopy
  • 01-00976NMR glass capillary sealing device
  • 03-00459Autofocus-control of a microscope including an electrically tunable lens
  • 15-00490Irradiation device and method for optical cochlear implants and laser surgery sytems
  • 21-00022Novel device for minimally-invasive optical stimulation of nerve cells
  • 32-00030Method and arrangement for identification and correction of optical aberrations
  • 32-00058Blood transfusion safety system Cairos
   Clear all

COVID-19 Related Technologies

  • Ref-No.Technology
  • 01-00897Lateral flow immunoassay with covalently clustered particles for enhanced sensitivity
  • 02-00311Cystobactamides – novel antibacterials against gram-negative pathogens
  • 03-00461Identifying Cellular States and Fate Transitions via Synthetic Locus Control Regions (sLCRs)
  • 07-00080Innovative plasmids and cells for SARS-CoV-2-specific research
  • 23-00080Neutralizing Antibodies for Treatment of COVID19 Infection
   Clear all